Loading clinical trials...
Loading clinical trials...
Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent System In Conjunction With Cataract Surgery: Extended Follow-up of the Premarket Cohort
The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100R/L in subjects previously enrolled in Glaukos Study GC-003.
The goal of this study was to demonstrate that use of this device in conjunction with cataract surgery did not result in a rate of sight-threatening adverse events, after 5 years of implantation that was higher than the rate of sight-threatening adverse events that occurred after cataract surgery alone, by more than a non-inferiority margin of 5%.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Beverly Hills, California, United States
Petaluma, California, United States
Sacramento, California, United States
San Clemente, California, United States
Santa Maria, California, United States
Parker, Colorado, United States
Boynton Beach, Florida, United States
Miami, Florida, United States
Tampa, Florida, United States
Morrow, Georgia, United States
Start Date
July 1, 2013
Primary Completion Date
April 1, 2014
Completion Date
April 1, 2014
Last Updated
April 15, 2016
108
ACTUAL participants
Lead Sponsor
Glaukos Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06865144